ISA101 and nivolumab for HPV-16+ cancer: updated clinical efficacy and immune correlates of response
暂无分享，去创建一个
Jing Wang | I. Wistuba | K. Rajapakshe | C. Coarfa | C. Melief | Jack J. Lee | W. William | M. Curran | R. Ferrarotto | E. Massarelli | B. Glisson | Qi Wang | Jack J Lee | Renee L Chin | J. Rodriguez Canales | T. Barrese | Faye M Johnson | Lei Feng | L. G. Sousa | Tomas Z Barrese